Glaukos Corp
NYSE:GKOS

Watchlist Manager
Glaukos Corp Logo
Glaukos Corp
NYSE:GKOS
Watchlist
Price: 138.62 USD -3.23% Market Closed
Market Cap: 7.6B USD
Have any thoughts about
Glaukos Corp?
Write Note

Glaukos Corp
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Glaukos Corp
Capital Expenditures Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Glaukos Corp
NYSE:GKOS
Capital Expenditures
-$10.7m
CAGR 3-Years
36%
CAGR 5-Years
1%
CAGR 10-Years
-26%
Becton Dickinson and Co
NYSE:BDX
Capital Expenditures
-$725m
CAGR 3-Years
15%
CAGR 5-Years
5%
CAGR 10-Years
-1%
Boston Scientific Corp
NYSE:BSX
Capital Expenditures
-$780m
CAGR 3-Years
-15%
CAGR 5-Years
-8%
CAGR 10-Years
-10%
Stryker Corp
NYSE:SYK
Capital Expenditures
-$634m
CAGR 3-Years
-9%
CAGR 5-Years
-1%
CAGR 10-Years
-11%
Abbott Laboratories
NYSE:ABT
Capital Expenditures
-$2.2B
CAGR 3-Years
-5%
CAGR 5-Years
-6%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Capital Expenditures
-$1.2B
CAGR 3-Years
-67%
CAGR 5-Years
-29%
CAGR 10-Years
-33%

See Also

What is Glaukos Corp's Capital Expenditures?
Capital Expenditures
-10.7m USD

Based on the financial report for Sep 30, 2024, Glaukos Corp's Capital Expenditures amounts to -10.7m USD.

What is Glaukos Corp's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-26%

Over the last year, the Capital Expenditures growth was 56%. The average annual Capital Expenditures growth rates for Glaukos Corp have been 36% over the past three years , 1% over the past five years , and -26% over the past ten years .

Back to Top